Method for protecting intestinal injury and intestinal flora

Through the study of puerarin, the intestinal damage and public health threat caused by salmonella infection were solved. It was found that it has a significant protective effect on chicks at a dose of 100mg/kg, improves growth performance and intestinal health, and provides antibiotic replacement potential solutions.

CN118957046APending Publication Date: 2024-11-15SHANXI AGRI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411060217.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Intestinal damage and public health threats caused by Salmonella infections, existing antibiotic use has led to an expansion of drug resistance spectrum, finding safer and more effective alternatives to protect gut health.

Method used

The chicks were studied experimentally by puerarin. Through 16S rRNA analysis and HPLC/ms metabolomics method, the prevention effect and mechanism of action in Salmonella infection were explored, and its application potential in livestock and poultry breeding was explored.

Benefits of technology

Puerarin significantly improves the growth performance of chicks at the dose of 100mg/kg, reduces intestinal damage, exerts anti-inflammatory effects, regulates intestinal flora, has the potential to replace antibiotics, and improves food safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118957046A_ABST
    Figure CN118957046A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of medicine preparation, and particularly relates to an intestinal injury and intestinal flora protection method which comprises the following specific operation steps: S1, experimental sample selection and grouping: selecting 360 1-day-old specific pathogen-free SPF white leghorns for an experiment, randomly dividing the white leghorns into 6 groups, repeating 6 in each group, and selecting a sample; according to the application, a chicken in-vivo salmonella infection model is constructed, various data indexes are integrated, the effect is optimal when the puerarin dosage is 100mg / kg, the puerarin has a protection effect on salmonella challenge, the growth performance of chickens can be improved, the damage of intestinal epithelial villus is improved, the anti-inflammatory effect is exerted, and the immune system of the body is protected. In addition, microbe 16S rRNA analysis finds that puerarin can resist inflammation and damage induced by salmonella by adjusting intestinal flora. Research results of the application show that puerarin has potential in the aspects of replacing antibiotics to control salmonella infection in poultry production and improving food safety.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of drug preparation, and in particular to a method for protecting intestinal damage and intestinal flora. Background Art

[0002] Salmonella is one of the important foodborne pathogens recognized worldwide. It is closely related to human daily life and poses a serious threat to public health and livestock and poultry farming. According to statistics, Salmonella causes a large number of human deaths every year worldwide. Poultry is the main target of Salmonella infection. It has a high pathogenicity to chicks under 1 week old. Some acute infections can cause death in chicks. Salmonella can spread through the food chain such as meat and egg products, infecting people and causing harm to public health. Antibiotics are commonly used therapeutic drugs in livestock and poultry production. Long-term irrational use of antibiotics to prevent and treat Salmonella infection has led to the continuous expansion of the Salmonella resistance spectrum. The abuse of antibiotics in the poultry industry also threatens public health. Therefore, it is now very necessary to find safer and more effective drugs to replace antibiotics and provide ideas for healthy livestock and poultry farming. Plant extracts have been identified as suitable antibiotic substitutes due to their effective antibacterial and antibacterial effects.

[0003] Puerarin is a flavonoid active ingredient isolated from Pueraria root. It is the main medicinal active ingredient in Pueraria root and has antibacterial, anti-inflammatory and antioxidant effects. Studies have reported that puerarin has anti-inflammatory and antioxidant effects on colitis mouse models, significantly inhibiting inflammatory responses by downregulating (NF-κB) and the secretion of pro-inflammatory mediators, and also exhibiting antioxidant effects by regulating the (Nrf2) pathway and antioxidant enzymes. When pigs are infected with epidemic diarrhea virus, studies have found that oral puerarin can reduce the incidence rate, improve the anti-inflammatory function and antioxidant capacity of the intestine, enhance the intestinal mucosal barrier and increase the abundance of beneficial intestinal bacteria. In poultry studies, it was found that puerarin can not only effectively prevent and treat inflammation caused by Mycoplasma gallisepticum, but also protect the lungs from damage. However, there have been no reports on the effects of puerarin on Salmonella and poultry intestinal damage. This application established a Salmonella infection model in chicks, explored the preventive effect of puerarin on Salmonella infection in chicks, studied the changes in the composition of the cecal flora through 16S rRNA analysis, and used HPLC / MS metabolomics to detect the changes in the serum metabolome of chicks in the challenge model, clarified the mechanism of action of puerarin on Salmonella infection in chicks, and provided a reference for the application of puerarin in livestock and poultry farming. Summary of the invention

[0004] The purpose of the present invention is to provide a method for protecting intestinal damage and intestinal flora to solve the problems raised in the above background technology.

[0005] To achieve the above object, the present invention provides the following technical solution: a method for protecting intestinal damage and intestinal flora, the specific operating steps of the method for protecting intestinal damage and intestinal flora are as follows:

[0006] S1 Experimental sampling and grouping: 360 one-day-old specific pathogen-free SPF white Leghorn chickens were randomly divided into 6 groups, with 6 replicates in each group and 10 chickens in each replicate. The groups were as follows: control group (CON), Salmonella enteritidis infection group (S), Salmonella enteritidis infection + 50 mg / kg puerarin group (P50), Salmonella enteritidis infection + 100 mg / kg puerarin group (P100), Salmonella enteritidis infection + 200 mg / kg puerarin group (P200), The chicks in the CON and S groups were fed with basal diets, while the chicks in the P50, P100, P200 and P400 groups were fed with puerarin at corresponding concentrations. The chicks were challenged with puerarin starting on the 6th day of feeding for three consecutive days. From the 6th to the 8th day, 1 mL (1×10 8 CFU / mL) of fresh Salmonella Enteritidis culture fluid, while the CON group was gavaged with an equal amount of sterile culture fluid. The birds in each group were housed individually and had free access to antibiotic-free feed and water;

[0007] S2 sample collection: Blood samples were collected from 6 chicks in each group on the 10th and 17th days, and then centrifuged at 4000g for 10 minutes at 4 degrees Celsius to obtain transparent serum. Approximately 2 cm of duodenum, jejunum and ileum were dissected and removed, slowly rinsed with PBS, and immersed in 4% paraformaldehyde for fixation for histological analysis. The cecal contents were collected for subsequent 16S rRNA sequencing and stored at -80°C until further analysis;

[0008] S3 Growth performance index determination: Record body weight on the 1st, 6th and 17th days to calculate the average daily weight gain (ADG), record the weight of feed consumption every three days, and then calculate the average daily feed intake (ADFI) and feed / gain ratio (Feed / Gain, F / G); ADG = (average body weight at the end of the experiment - average body weight at the beginning of the experiment) / number of experimental days, ADFI = (total amount of feed - remaining feed weight) / number of experimental days × number of chickens in each group, F / G = ADFI / ADG;

[0009] S4 Serum enzyme-linked immunosorbent assay: The levels of inflammatory factors (TNF-α, IFN-γ, IL-1 and IL-6) and immunoglobulins (IgM, IgG and IgA) were measured by Elisa kit (COIBO BIO, Shanghai hai, China) and microplate reader;

[0010] S5 Observation of intestinal tissue morphology: The intestinal tissue obtained was fixed in 4% paraformaldehyde, dehydrated with ethanol, embedded in paraffin, and sliced ​​into 5 μm thick sections, stained with hematoxylin and eosin (HE), and sealed with neutral gum for preservation;

[0011] S6 Intestinal flora analysis: S6.1, total DNA extraction; S6.2, PCR amplification; S6.3, PE library and Illumina sequencing; S6.4, bioinformatics analysis;

[0012] S7 Statistical analysis: SPSS 21.0 (IBM, USA) was used to analyze the data in this experiment. The data were expressed as mean ± standard error (Mean ± SEM). * represents p < 0.05, indicating that the data between the groups are significantly different; ** represents p < 0.01, indicating that the data between the groups are extremely significantly different.

[0013] S8 Result analysis: The results of the effect of puerarin on the growth performance of chicks infected with Salmonella, the effect of puerarin on the intestinal tissue morphology of chicks infected with Salmonella, the changes in serum inflammatory factors and immunoglobulin levels, and the effect of puerarin on the cecal microbial composition of infected chicks were obtained;

[0014] S9 Discussion and analysis: Observe the changes in intestinal tissue morphology, observe the improvement of intestinal inflammation, and observe the effects on intestinal flora.

[0015] Preferably, the specific operating steps of the S4 serum enzyme-linked immunosorbent assay are as follows:

[0016] (1) Sampling: Standards and samples were added to different wells. 50 μL of each concentration of standard was added to each well. 40 μL of diluent was first added to each sample well, followed by 10 μL of sample.

[0017] (2) Add enzyme: add 100 μl of enzyme labeling reagent to the standard well and sample well respectively;

[0018] (3) Incubation: After adding the sample, the 96-well plate was sealed with a membrane and incubated at 37°C for 60 minutes;

[0019] (4) Liquid preparation: dilute the concentrated washing solution 20 times with distilled water for later use;

[0020] (5) Washing: Gently peel off the sealing film, discard the liquid in the wells, add the slowly diluted washing solution to each well, let it stand for 30 seconds and then pour it out. Repeat this step 5 times;

[0021] (6) Color development: Add 50 μl of color developer A and B to each well in sequence, mix gently, and place at 37°C in the dark for 15 min;

[0022] (7) Termination: Add 50 μl of stop solution to each well to terminate the reaction;

[0023] (8) Measurement: Set the blank well to zero as a control and measure the absorbance value at a wavelength of 450 nm.

[0024] Preferably, the specific steps of observing the S5 intestinal tissue morphology are as follows:

[0025] (1) Tissue dehydration: The fixed intestinal tissue blocks were dehydrated step by step, once in 70% ethanol for 2 h, 80% ethanol for 2 h, 85% ethanol for 1 h, 90% ethanol for 1 h, the first time in 95% ethanol for 30 min, the second time in 95% ethanol II for 30 min, 100% ethanol I for 20 min, and 100% ethanol II for 20 min, performing step-by-step alcohol dehydration;

[0026] (2) Transparency: After dehydration, perform transparency treatment by mixing anhydrous ethanol and xylene in a ratio of 1:1, transparentize for 20 min, then place in xylene I for 30 min, and place in xylene II for 45 min;

[0027] (3) Embedding: The transparent sample is placed in an embedding machine for wax immersion for 2.5 hours;

[0028] (4) Paraffin sectioning: The embedded wax block samples were fixed on a microtome, the slice thickness was adjusted to 5 μm, and then the slices were sliced ​​manually continuously. The continuous slices were placed in a slide spreader and spread evenly with a brush;

[0029] (5) HE staining: First, dewax the paraffin sections to water, place them in xylene I and II for 10 min each for dewaxing, then rehydrate them in graded alcohols, in order, go through anhydrous ethanol I and II for 3 min each, 95% ethanol I and II for 3 min each, 90% ethanol for 3 min, 80% and 70% ethanol for 2 min each, and finally place them in distilled water for 3 min; then immerse them in hematoxylin for 5-8 min, rinse them under running water, differentiate them, place them in 1% hydrochloric acid alcohol for 5 s, rinse them in tap water for 10-20 min, then immerse them in 70%, 80% and 90% ethanol for 2 min each, and finally immerse them in eosin staining solution for 30 s;

[0030] (6) Dehydration of sections: Dehydrate the sections by passing through 95% ethanol I and II and anhydrous ethanol I and II for 5 min each;

[0031] (7) Section transparentization: Place the sample sections in xylene I and II for 10 min each to make them transparent;

[0032] (8) Sealing: Perform this procedure in a fume hood. Use neutral gum to slowly seal the slides. Use tweezers to gently press the coverslip to avoid creating bubbles. Wait for it to dry.

[0033] (9) Microscopic observation: Use an Olympus AX70 microscope to observe the sections under bright field, select different fields of view to take pictures, measure the villus height (VH) and crypt depth (CD) of each intestinal segment, and then calculate the ratio of the two (VH:CD).

[0034] Preferably, the primers for the primer expansion correspond to the V3-V4 region of 16SrRNA, the upstream primer 338F: ACTCCTACGGGAGGCAGCAG; the downstream primer 806R: GGACTACHVGGGTWTCTAAT; the amplification conditions require a low cycle number for amplification to ensure the accuracy and reliability of data analysis, and secondly to ensure the uniformity of the sample amplification cycle number.

[0035] Preferably, the PE library and Illumina sequencing are constructed using a NEXTFLEX Rapid DNA-Seq kit and then subjected to Illumina sequencing.

[0036] Preferably, the bioinformatics analysis uses fastp software to quality control the original sequencing sequence, spliced ​​by FLASH software: then the sequence is OTU clustered by UPARSE software, RDP classifier is compared with the 16S rRNA database for OTU classification annotation, PICRUSt2 software is used to predict and analyze 16S functions, and the DADA2 plug-in in the Qiime2 process is used to optimize the sequence noise reduction. All data are analyzed on the Meiji Biocloud platform, mothur software is used for Alpha diversity analysis, and Wilxocon rank sum test is used for inter-group difference analysis of Alpha diversity; LEfSe analysis determines the bacterial groups with significant differences in abundance between different groups from phylum to genus, and species are selected based on spearman correlation for correlation network diagram analysis.

[0037] Compared with the prior art, the present invention has the following beneficial effects:

[0038] This application constructs a Salmonella infection model in chicks. Based on various data indicators, the best effect is achieved when the puerarin dose is 100 mg / kg. It has a protective effect on the attack of Salmonella, can improve the growth performance of chicks, improve the damage of intestinal epithelial villi, play an anti-inflammatory role, and protect the body's immune system. In addition, through microbial 16S rRNA analysis, it was found that puerarin can resist the inflammation and damage induced by Salmonella by regulating the intestinal flora. The research results of this application show that puerarin has potential in replacing antibiotics to control Salmonella infection in poultry production and improve food safety. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] Figure 1 HE staining comparison of intestinal tissues of chicks at different ages (A. HE staining of duodenum, jejunum and ileum tissue sections of 10-day-old chicks. B. HE staining of duodenum, jejunum and ileum tissue sections of 17-day-old chicks, scale bar = 100 μm);

[0040] Figure 2 The OTU analysis diagrams of the three groups of intestinal flora (A is the Venn diagram of OTU; B is the dilution curve of cecal microbial samples; C is the Shannon curve);

[0041] Figure 3 Pie charts were formed for the microbial communities at the phylum level;

[0042] Figure 4 The relative abundance difference of the genus and the relative abundance difference of the microbial community composition at the genus level;

[0043] Figure 5 The evolutionary graph and LDA score graph of the intestinal flora. DETAILED DESCRIPTION

[0044] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0045] In the description of the present invention, it is necessary to understand that the terms "upper", "lower", "front", "back", "left", "right", "top", "bottom", "inside", "outside", etc., indicating the orientation or position relationship are based on the orientation or position relationship shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation on the present invention.

[0046] Example:

[0047] See also Figure 1-5 , the present invention provides a technical solution:

[0048] A method for protecting intestinal damage and intestinal flora, the specific operating steps of the method for protecting intestinal damage and intestinal flora are as follows:

[0049] S1 Experimental sampling and grouping: 360 one-day-old specific pathogen-free SPF white Leghorn chickens were randomly divided into 6 groups, with 6 replicates in each group and 10 chickens in each replicate. The groups were as follows: control group (CON), Salmonella enteritidis infection group (S), Salmonella enteritidis infection + 50 mg / kg puerarin group (P50), Salmonella enteritidis infection + 100 mg / kg puerarin group (P100), Salmonella enteritidis infection + 200 mg / kg puerarin group (P200), The chicks in the CON and S groups were fed with basal diets, while the chicks in the P50, P100, P200 and P400 groups were fed with puerarin at corresponding concentrations. The chicks were challenged with puerarin starting on the 6th day of feeding for three consecutive days. From the 6th to the 8th day, 1 mL (1×10 8 CFU / mL) of fresh Salmonella Enteritidis culture fluid, while the CON group was gavaged with an equal amount of sterile culture fluid. The birds in each group were housed individually and had free access to antibiotic-free feed and water;

[0050] S2 sample collection: Blood samples were collected from 6 chicks in each group on the 10th and 17th days, and then centrifuged at 4000g for 10 minutes at 4 degrees Celsius to obtain transparent serum. Approximately 2 cm of duodenum, jejunum and ileum were dissected and removed, slowly rinsed with PBS, and immersed in 4% paraformaldehyde for fixation for histological analysis. The cecal contents were collected for subsequent 16S rRNA sequencing and stored at -80°C until further analysis;

[0051] S3 Growth performance index determination: Record body weight on the 1st, 6th and 17th days to calculate the average daily weight gain (ADG), record the weight of feed consumption every three days, and then calculate the average daily feed intake (ADFI) and feed / gain ratio (Feed / Gain, F / G); ADG = (average body weight at the end of the experiment - average body weight at the beginning of the experiment) / number of experimental days, ADFI = (total amount of feed - remaining feed weight) / number of experimental days × number of chickens in each group, F / G = ADFI / ADG;

[0052] S4 Serum enzyme-linked immunosorbent assay: The levels of inflammatory factors (TNF-α, IFN-γ, IL-1 and IL-6) and immunoglobulins (IgM, IgG and IgA) were measured by Elisa kit (COIBO BIO, Shanghai hai, China) and microplate reader;

[0053] S5 Observation of intestinal tissue morphology: The intestinal tissue obtained was fixed in 4% paraformaldehyde, dehydrated with ethanol, embedded in paraffin, and sliced ​​into 5 μm thick sections, stained with hematoxylin and eosin (HE), and sealed with neutral gum for preservation;

[0054] S6 Intestinal flora analysis: S6.1, total DNA extraction; S6.2, PCR amplification; S6.3, PE library and Illumina sequencing; S6.4, bioinformatics analysis;

[0055] S7 Statistical analysis: SPSS 21.0 (IBM, USA) was used to analyze the data in this experiment. The data were expressed as mean ± standard error (Mean ± SEM). * represents p < 0.05, indicating that the data between the groups are significantly different; ** represents p < 0.01, indicating that the data between the groups are extremely significantly different.

[0056] S8 Result analysis: The results of the effect of puerarin on the growth performance of chicks infected with Salmonella, the effect of puerarin on the intestinal tissue morphology of chicks infected with Salmonella, the changes in serum inflammatory factors and immunoglobulin levels, and the effect of puerarin on the cecal microbial composition of infected chicks were obtained;

[0057] S9 Discussion and analysis: Observe the changes in intestinal tissue morphology, observe the improvement of intestinal inflammation, and observe the effects on intestinal flora.

[0058] The specific operation steps of the S4 serum ELISA are as follows:

[0059] (1) Sampling: Standards and samples were added to different wells. 50 μL of each concentration of standard was added to each well. 40 μL of diluent was first added to each sample well, followed by 10 μL of sample.

[0060] (2) Add enzyme: add 100 μl of enzyme labeling reagent to the standard well and sample well respectively;

[0061] (3) Incubation: After adding the sample, the 96-well plate was sealed with a membrane and incubated at 37°C for 60 minutes;

[0062] (4) Liquid preparation: dilute the concentrated washing solution 20 times with distilled water for later use;

[0063] (5) Washing: Gently peel off the sealing film, discard the liquid in the wells, add the slowly diluted washing solution to each well, let it stand for 30 seconds and then pour it out. Repeat this step 5 times;

[0064] (6) Color development: Add 50 μl of color developer A and B to each well in sequence, mix gently, and place at 37°C in the dark for 15 min;

[0065] (7) Termination: Add 50 μl of stop solution to each well to terminate the reaction;

[0066] (8) Measurement: Set the blank well to zero as a control and measure the absorbance value at a wavelength of 450 nm.

[0067] The specific steps of the S5 intestinal tissue morphology observation are as follows:

[0068] (1) Tissue dehydration: The fixed intestinal tissue blocks were dehydrated step by step, once in 70% ethanol for 2 h, 80% ethanol for 2 h, 85% ethanol for 1 h, 90% ethanol for 1 h, the first time in 95% ethanol for 30 min, the second time in 95% ethanol II for 30 min, 100% ethanol I for 20 min, and 100% ethanol II for 20 min, performing step-by-step alcohol dehydration;

[0069] (2) Transparency: After dehydration, perform transparency treatment by mixing anhydrous ethanol and xylene in a ratio of 1:1, transparentize for 20 min, then place in xylene I for 30 min, and place in xylene II for 45 min;

[0070] (3) Embedding: The transparent sample is placed in an embedding machine for wax immersion for 2.5 hours;

[0071] (4) Paraffin sectioning: The embedded wax block samples were fixed on a microtome, the slice thickness was adjusted to 5 μm, and then the slices were sliced ​​manually continuously. The continuous slices were placed in a slide spreader and spread evenly with a brush;

[0072] (5) HE staining: First, dewax the paraffin sections to water, place them in xylene I and II for 10 min each for dewaxing, then rehydrate them in graded alcohols, in order, go through anhydrous ethanol I and II for 3 min each, 95% ethanol I and II for 3 min each, 90% ethanol for 3 min, 80% and 70% ethanol for 2 min each, and finally place them in distilled water for 3 min; then immerse them in hematoxylin for 5-8 min, rinse them under running water, differentiate them, place them in 1% hydrochloric acid alcohol for 5 s, rinse them in tap water for 10-20 min, then immerse them in 70%, 80% and 90% ethanol for 2 min each, and finally immerse them in eosin staining solution for 30 s;

[0073] (6) Dehydration of sections: Dehydrate the sections by passing through 95% ethanol I and II and anhydrous ethanol I and II for 5 min each;

[0074] (7) Section transparentization: Place the sample sections in xylene I and II for 10 min each to make them transparent;

[0075] (8) Sealing: Perform this procedure in a fume hood. Use neutral gum to slowly seal the slides. Use tweezers to gently press the coverslip to avoid creating bubbles. Wait for it to dry.

[0076] (9) Microscopic observation: Use an Olympus AX70 microscope to observe the sections under bright field, select different fields of view to take pictures, measure the villus height (VH) and crypt depth (CD) of each intestinal segment, and then calculate the ratio of the two (VH:CD).

[0077] The primers for the primer expansion correspond to the V3-V4 region of 16SrRNA, the upstream primer 338F: ACTCCTACGGGAGGCAGCAG; the downstream primer 806R: GGACTACHVGGGTWTCTAAT; the amplification conditions require a low cycle number for amplification to ensure the accuracy and reliability of data analysis, and secondly to ensure the uniformity of the sample amplification cycle number.

[0078] The PE library and Illumina sequencing were constructed using a NEXTFLEX Rapid DNA-Seq kit, followed by Illumina sequencing.

[0079] The bioinformatics analysis was performed by quality control of the original sequencing sequence using fastp software and splicing with FLASH software: UPARSE software was used to cluster the sequences into OTUs, RDP classifier was used to compare the 16SrRNA database for OTU classification annotation, PICRUSt2 software was used to predict and analyze the 16S function, and the DADA2 plug-in in the Qiime2 process was used to optimize the sequence noise reduction. All data were analyzed on the Meiji Biocloud platform, mothur software was used for Alpha diversity analysis, and Wilxocon rank sum test was used for inter-group difference analysis of Alpha diversity; LEfSe analysis determined the bacterial groups with significant differences in abundance between different groups from phylum to genus, and species were selected based on spearman correlation for correlation network diagram analysis.

[0080] Experimental animals: 360 1-day-old SPF white Leghorn chickens weighing 40±2.35g were selected for the experiment. The feeding equipment was cleaned and disinfected before the experiment. In the first week of the experiment, the temperature range of the chicken house was controlled at 32-34℃, and the humidity was maintained at about 65%; one week later, the temperature range of the chicken house was controlled at 30-32℃, the humidity of the chicken house was maintained at about 60%, and the temperature was reduced by about 0.5℃ every day until the temperature of the chicken house was maintained at 26℃. The chickens were free to eat and drink water, and the troughs and feed troughs were cleaned every morning and evening, and the chicken house was cleaned, and the health and morbidity were recorded every day. All experiments were conducted in accordance with the "Regulations on the Management of Experimental Animals";

[0081] Experimental strains: The experimental strains were collected from diseased materials in a farm in Mudan District, Heze City, Shandong Province. They have been identified as Salmonella Enteritidis and obtained a Gene Bank number (OP800234.1). The strain was inoculated into 100mL of liquid LB culture medium, sealed and placed in a shaker at 160r / min for overnight culture until it was in the logarithmic growth phase. According to the plate count and OD600 value data in the preliminary test, the concentration of the bacterial suspension obtained at this time was 5×108cfu / mL. The cultured bacterial suspension was centrifuged at 8000r / min for 10min, and the bacterial precipitate was collected after a second centrifugation. The bacteria were then resuspended in sterile PBS to a quantitative value of 5×109cfu / mL and stored at 4°C for later use;

[0082] Drugs and reagents:

[0083] Main reagents and manufacturers

[0084]

[0085] Main instruments:

[0086]

[0087] Main reagent configuration method:

[0088] LB medium: weigh 5 g yeast extract, 10 g tryptone and 10 g sodium chloride into a clean beaker, adjust the pH to 7.0 with 5 mol / L NaOH, dilute to 1 L with deionized water, sterilize at 121°C for 20 min, and store at 4°C for later use;

[0089] Puerarin: Weigh 20 mg of puerarin powder (99.9%) and dissolve it in 200 μL of DMSO to make a stock concentration of 100 mg / mL;

[0090] PBS preparation: weigh 7.9 g of sodium chloride, 0.2 g of KCl, 0.24 g of KH2PO4 and 1.8 g of K2HPO4 and dissolve them in 800 ml of distilled water, adjust the pH of the solution to 7.4, and finally make up to 1 L and store at 4°C for later use;

[0091] Effects of puerarin on growth performance of chicks infected with Salmonella:

[0092] The following table lists the growth performance indicators of chicks in two growth stages. It can be seen that 1-6 days before infection with Salmonella Enteritidis, compared with the CON group, the puerarin dosage groups had no significant effect on the ADG and ADFI of the chicks (P<0.05). In the second stage (7-10d), compared with the CON group, the growth performance of the chicks in the S group decreased, the ADFI and F / G values ​​increased, the ADG value decreased, and the ADG and F / G changed significantly (P<0.05). Compared with the CON group, the ADG values ​​of the P50, P100, P200, and P400 groups decreased; the F / G values ​​of the P50, P100, P200, and P400 groups increased. In the third stage (11-17d), the ADG and ADFI values ​​of the S group were lower than those of the CON group, and the F / G value was higher than that of the CON group (p<0.05); there was no significant difference in the ADG, ADFI, and F / G values ​​between the P100 group and the CON group (Table 3-3).

[0093] Effects of puerarin on growth performance of chickens infected with Salmonella enteritidis

[0094]

[0095]

[0096] Note: Abbreviations: CON control group; S enteritidis infection group; P50 enteritidis infection + puerarin group 50 mg / kg; P100 enteritidis infection + puerarin group 100 mg / kg; P200 enteritidis infection + puerarin group 200 mg / kg; P400 enteritidis infection + puerarin group 400 mg / kg;

[0097] Effect of puerarin on intestinal tissue morphology of chicks infected with Salmonella: In order to further study the effect of puerarin, the intestinal tissue morphology of chicks in each group was compared and evaluated. HE staining of samples on the 10th day showed that the intestinal epithelial villi in the duodenum, jejunum, and ileum of the S group were more severely damaged than those in the CON group, with varying degrees of villus rupture, uneven arrangement of villi, partial erosion of the mucosal layer, decreased VH values ​​of each intestinal segment, and increased CD values ​​( Figure 1). The CD value of the duodenal samples in the S group increased significantly (p<0.05), and the VH:CD ratio decreased on the 10th day. Compared with the S group, the amount of damage in different intestinal segments in the P100 and P200 groups decreased. On the contrary, the VH value and the VH:CD ratio increased (as shown in the table below). There was no significant difference in the CD and VH:CD ratio values ​​between the P100 group and the CON group. On the 17th day, compared with the CON group, the intestinal epithelial villi in the S group were severely damaged, and the uniformity and integrity of the villi were significantly damaged; the mucosal layer was also affected to a certain extent, with increased CD, decreased VH value and VH:CD ratio. Compared with the S group, the degree of intestinal epithelial villi damage in the P100 group was reduced, and the CD of all puerarin-treated groups decreased, VH increased, and the VH:CD value increased. This indicates that puerarin has a repairing effect on intestinal epithelial villi damage caused by Salmonella enteritidis;

[0098] Effects of puerarin on intestinal tissue morphology of chickens challenged with Salmonella enteritidis

[0099]

[0100]

[0101]

[0102] Note: SEM stands for standard error of the mean (n=6). abcd, superscripts with different letters in the same row indicate significant differences (P<0.05);

[0103] Changes in serum inflammatory factors and immunoglobulin levels:

[0104] As shown in the table below, on the 10th day, the levels of IL-1β and IL-6 in the S group were significantly higher than those in the CON group (P<0.001), the level of IgM decreased, and the concentration of IgA increased significantly (P<0.001). Compared with the S group, with the increase of puerarin concentration, the levels of IL-1 and IL-6 first decreased and then increased, with the lowest level in the P100 group. In contrast, the levels of IgM, IgG, and IgA showed a pattern of first increasing and then decreasing, but they were all the highest in the P100 group. The IL-1 and IL-6 contents of the P100 group and the CON group were basically the same, while the IgM, IgG, and IgA contents of the P100 group were significantly higher than those of the CON group. On the 17th day, the levels of IFN-γ, TNF-α, IL-6, and IL-1β in the S group were significantly higher than those in the CON group. On the contrary, the levels of IgM, IgG, and IgA decreased, among which the decrease in IgM was the most significant. Compared with the S group, with the increase of puerarin concentration, the contents of IFN-γ, TNF-α, IL-1, and IL-6 first decreased and then increased, with the lowest in the P100 group. The contents of IgM, IgG, and IgA showed a trend of first increasing and then decreasing, reaching the highest value in the P100 group. There was no significant difference in the levels of IFN-γ, TNF-α, IL-6, IL-1β, IgM, IgG, and IgA between the P100 group and the CON group. On the 17th day, compared with the CON group, the concentrations of IFN-γ, TNF-α, IL-1β, and IL-6 in the S group were the highest. On the 10th day, compared with the CON group, the concentrations of IFN-γ, IL-1β, and IL-6 in the S group were the highest. In summary, the S group had a significant inflammatory response, and 100 mg / kg puerarin could enhance immune function and reduce the production of inflammatory factors.

[0105] Effects of puerarin on immune function of chickens exposed to Salmonella enteritidis

[0106]

[0107]

[0108]

[0109] Note: SEM stands for standard error of the mean (n=6). abcd, superscripts with different letters in the same row indicate significant differences (P<0.05);

[0110] Effects of puerarin on the cecal microbial composition of infected chicks:

[0111] Intestinal flora OTU analysis:

[0112] 903,973 optimized sequences were obtained by 16S rDNA amplicon sequencing technology, with a total of 375,978,442 bases. The average sequence length of the samples was 415 bp. OTU clustering analysis and species classification annotation were performed based on 97% OTU sequence similarity. The Venn diagram was selected to visualize the common or unique OTUs in the three groups of samples, such as Figure 2 As shown in A, the number of OTUs obtained from the three groups of samples, con group, S group, and P group, were 341, 341, and 333, respectively. The number of common OTUs in the three groups of samples was 292, and the number of unique OTUs in the con group, S group, and P group were 9, 12, and 8, respectively. The con group shared 314 and 310 OTUs with the S group and the P group, respectively, and the S group and the P group shared 307 OTUs. Figure 2 As can be seen from the BC, with the increase in sampling volume, the dilution curve tends to be flat when the sequencing reaches 10,000, indicating that the measured data volume is rich and the sample sequencing depth is sufficient to cover the composition of all microbial communities;

[0113] Analysis results of α-diversity of intestinal flora:

[0114] Alpha diversity analysis can reflect the species abundance and diversity of the microbial community, which are reflected by the species richness index (Chao index and Ace index) and diversity index (Shannon index and Simpson index). As shown in the table below, the Shannon index, Simpson index, Chao index and Ace index show that there is no significant difference between the results of the treatment groups (P>0.05). At the same time, the Chao index, Ace index and Shannon index of the S group are higher than those of the con group. The results show that the diversity and richness of the intestinal flora in each treatment group are not significantly affected, and it is speculated that the intestinal flora may be affected by the composition structure of the microorganisms.

[0115] Changes in α-diversity index:

[0116]

[0117] Microbial community composition analysis results:

[0118] At the phylum level, the analysis found that the microbial communities in each group were composed of Firmicutes, Bacteroidota, Proteobacteria, Actinobacteria and a few other microorganisms. The proportions of the CON group at the phylum level were 93.13%, 5.5%, 0.46%, 0.38% and 0.48%, respectively; the proportions of the S group were 86.93%, 8.33%, 2.82%, 1.40% and 0.52%, respectively; the proportions of the P group were 91.75%, 6.27%, 0.66%, 1.06% and 0.25%, respectively. Figure 3 ). Compared with the con group, the abundance of Bacteroidota, Proteobacteria and Actinobacteria increased, and the abundance of Firmicutes decreased in the S group, while the P group reversed this trend, indicating that puerarin has a regulatory effect on the intestinal flora imbalance caused by Salmonella in chicks.

[0119] At the genus level, the relative abundances of Subdoligranulum, Faecalibacterium, and Lactobacillus spp. were lower in the S group than in the CON group, while the relative abundances of Lactobacillus, Faecalibacterium, and Subdoligranulum were higher in the P group. The abundances of Enterococcus and Shigella increased in the S group compared with the CON group, while decreased in the P group ( Figure 4 ). The abundance of Enterococcus and Shigella in the CON group did not change significantly compared with the P group. The abundance of lactic acid bacteria in the S group was significantly reduced compared with the control group. The abundance of lactic acid bacteria in the P group was significantly increased compared with the S group. There was no statistically significant difference between the CON group and the P group. The CON group did not contain Salmonella. The abundance of Salmonella in the S group was significantly increased compared with the CON group. The abundance of Salmonella in the P group was significantly reduced compared with the S group ( Figure 4 ). The abundance of Ruminococcaceae in the CON group was lower than that in the P group. The study found that Subdoligranulum ferments in the intestine to produce butyrate, which can protect the intestine and maintain body health. It was also found that Subdoligranulum has the potential to treat necrotizing colitis.

[0120] The LDA values ​​showed the results of LEfSe analysis, indicating that the relative abundances of eubacterium_coprostanoligen_group, Barnesiellaceae, Christensenella, Barnesiella, norank_f_eubacterium_coprostanoligenes group, and Anaerovoracaceae in the S group were significantly higher than those in the other groups, while the relative abundance of Ruminococcaceae in the P group was significantly higher than that in the other groups ( Figure 5 );

[0121] The above shows and describes the basic principles and main features of the present invention and the advantages of the present invention. For those skilled in the art, it is obvious that the present invention is not limited to the details of the above exemplary embodiments, and the present invention can be implemented in other specific forms without departing from the spirit or basic features of the present invention; therefore, no matter from which point of view, the embodiments should be regarded as exemplary and non-restrictive. The scope of the present invention is limited by the attached claims rather than the above description. Therefore, it is intended to include all changes within the meaning and scope of the equivalent elements of the claims in the present invention, and any figure marks in the claims should not be regarded as limiting the claims involved.

[0122] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A method for protecting intestinal damage and intestinal flora, characterized in that: The specific operation steps of the intestinal damage and intestinal flora protection method are as follows: S1 Experimental sampling and grouping: 360 one-day-old specific pathogen-free SPF white Leghorn chickens were randomly divided into 6 groups, with 6 replicates in each group and 10 chickens in each replicate. The groups were as follows: control group (CON), Salmonella enteritidis infection group (S), Salmonella enteritidis infection + 50 mg / kg puerarin group (P50), Salmonella enteritidis infection + 100 mg / kg puerarin group (P100), Salmonella enteritidis infection + 200 mg / kg puerarin group (P200), The chicks in the CON and S groups were fed with basal diets, while the chicks in the P50, P100, P200 and P400 groups were fed with puerarin at corresponding concentrations. The chicks were challenged with puerarin starting on the 6th day of feeding for three consecutive days. From the 6th to the 8th day, 1 mL (1×10 8 CFU / mL) of fresh Salmonella Enteritidis culture fluid, while the CON group was gavaged with an equal amount of sterile culture fluid. The birds in each group were housed individually and had free access to antibiotic-free feed and water; S2 sample collection: Blood samples were collected from 6 chicks in each group on the 10th and 17th days, and then centrifuged at 4000g for 10 minutes at 4 degrees Celsius to obtain transparent serum. Approximately 2 cm of duodenum, jejunum and ileum were dissected and removed, slowly rinsed with PBS, and immersed in 4% paraformaldehyde for fixation for histological analysis. The cecal contents were collected for subsequent 16S rRNA sequencing and stored at -80°C until further analysis; S3 Growth performance index determination: Record body weight on the 1st, 6th and 17th days to calculate the average daily weight gain (ADG), record the weight of feed consumption every three days, and then calculate the average daily feed intake (ADFI) and feed / gain ratio (Feed / Gain, F / G); ADG = (average body weight at the end of the experiment - average body weight at the beginning of the experiment) / number of experimental days, ADFI = (total amount of feed - remaining feed weight) / number of experimental days × number of chickens in each group, F / G = ADFI / ADG; S4 Serum enzyme-linked immunosorbent assay: The levels of inflammatory factors (TNF-α, IFN-γ, IL-1 and IL-6) and immunoglobulins (IgM, IgG and IgA) were measured by Elisa kit (COIBO BIO, Shanghai hai, China) and microplate reader; S5 Observation of intestinal tissue morphology: The intestinal tissue obtained was fixed in 4% paraformaldehyde, dehydrated with ethanol, embedded in paraffin, and sliced ​​into 5 μm thick sections, stained with hematoxylin and eosin (HE), and sealed with neutral gum for preservation; S6 Intestinal flora analysis: S6.1, total DNA extraction; S6.2, PCR amplification; S6.3, PE library and Illumina sequencing; S6.4, bioinformatics analysis; S7 Statistical analysis: SPSS 21.0 (IBM, USA) was used to analyze the data in this experiment. The data were expressed as mean ± standard error (Mean ± SEM). * represents p < 0.05, indicating that the data between the groups are significantly different; ** represents p < 0.01, indicating that the data between the groups are extremely significantly different. S8 Result analysis: The results of the effect of puerarin on the growth performance of chicks infected with Salmonella, the effect of puerarin on the intestinal tissue morphology of chicks infected with Salmonella, the changes in serum inflammatory factors and immunoglobulin levels, and the effect of puerarin on the cecal microbial composition of infected chicks were obtained; S9 Discussion and analysis: Observe the changes in intestinal tissue morphology, observe the improvement of intestinal inflammation, and observe the effects on intestinal flora.

2. A method for protecting intestinal damage and intestinal flora according to claim 1, characterized in that: The specific operation steps of the S4 serum ELISA are as follows: (1) Sampling: Standards and samples were added to different wells. 50 μL of each concentration of standard was added to each well. 40 μL of diluent was first added to each sample well, followed by 10 μL of sample. (2) Add enzyme: add 100 μl of enzyme labeling reagent to the standard well and sample well respectively; (3) Incubation: After adding the sample, the 96-well plate was sealed with a membrane and incubated at 37°C for 60 minutes; (4) Liquid preparation: dilute the concentrated washing solution 20 times with distilled water for later use; (5) Washing: Gently peel off the sealing film, discard the liquid in the wells, add the slowly diluted washing solution to each well, let it stand for 30 seconds and then pour it out. Repeat this step 5 times; (6) Color development: Add 50 μl of color developer A and B to each well in sequence, mix gently, and place at 37°C in the dark for 15 min; (7) Termination: Add 50 μl of stop solution to each well to terminate the reaction; (8) Measurement: Set the blank well to zero as a control and measure the absorbance value at a wavelength of 450 nm.

3. A method for protecting intestinal damage and intestinal flora according to claim 1, characterized in that: The specific steps of the S5 intestinal tissue morphology observation are as follows: (1) Tissue dehydration: The fixed intestinal tissue blocks were dehydrated step by step, once in 70% ethanol for 2 h, 80% ethanol for 2 h, 85% ethanol for 1 h, 90% ethanol for 1 h, the first time in 95% ethanol for 30 min, the second time in 95% ethanol II for 30 min, 100% ethanol I for 20 min, and 100% ethanol II for 20 min, performing step-by-step alcohol dehydration; (2) Transparency: After dehydration, perform transparency treatment by mixing anhydrous ethanol and xylene in a ratio of 1:1, transparentize for 20 min, then place in xylene I for 30 min, and place in xylene II for 45 min; (3) Embedding: The transparent sample is placed in an embedding machine for wax immersion for 2.5 hours; (4) Paraffin sectioning: The embedded wax block samples were fixed on a microtome, the slice thickness was adjusted to 5 μm, and then the slices were sliced ​​manually continuously. The continuous slices were placed in a slide spreader and spread evenly with a brush; (5) HE staining: First, dewax the paraffin sections to water, place them in xylene I and II for 10 min each for dewaxing, then rehydrate them in graded alcohols, in order, go through anhydrous ethanol I and II for 3 min each, 95% ethanol I and II for 3 min each, 90% ethanol for 3 min, 80% and 70% ethanol for 2 min each, and finally place them in distilled water for 3 min; then immerse them in hematoxylin for 5-8 min, rinse them under running water, differentiate them, place them in 1% hydrochloric acid alcohol for 5 s, rinse them in tap water for 10-20 min, then immerse them in 70%, 80% and 90% ethanol for 2 min each, and finally immerse them in eosin staining solution for 30 s; (6) Dehydration of sections: Dehydrate the sections by passing through 95% ethanol I and II and anhydrous ethanol I and II for 5 min each; (7) Section transparentization: Place the sample sections in xylene I and II for 10 min each to make them transparent; (8) Sealing: Perform this procedure in a fume hood. Use neutral gum to slowly seal the slides. Use tweezers to gently press the coverslip to avoid creating bubbles. Wait for it to dry. (9) Microscopic observation: Use an Olympus AX70 microscope to observe the sections under bright field, select different fields of view to take pictures, measure the villus height (VH) and crypt depth (CD) of each intestinal segment, and then calculate the ratio of the two (VH:CD).

4. A method for protecting intestinal damage and intestinal flora according to claim 1, characterized in that: The primers for the primer expansion correspond to the V3-V4 region of 16SrRNA, the upstream primer 338F: ACTCCTACGGGAGGCAGCAG; the downstream primer 806R: GGACTACHVGGGTWTCTAAT; the amplification conditions require a low cycle number for amplification to ensure the accuracy and reliability of data analysis, and secondly to ensure the uniformity of the sample amplification cycle number.

5. A method for protecting intestinal damage and intestinal flora according to claim 1, characterized in that: The PE library and Illumina sequencing were constructed using a NEXTFLEX Rapid DNA-Seq kit, followed by Illumina sequencing.

6. A method for protecting intestinal damage and intestinal flora according to claim 1, characterized in that: The bioinformatics analysis was performed by quality control of the original sequencing sequence using fastp software and splicing with FLASH software: UPARSE software was used to cluster the sequences into OTUs, RDP classifier was used to compare the 16SrRNA database for OTU classification annotation, PICRUSt2 software was used to predict and analyze the 16S function, and the DADA2 plug-in in the Qiime2 process was used to optimize the sequence noise reduction. All data were analyzed on the Meiji Biocloud platform, mothur software was used for Alpha diversity analysis, and Wilxocon rank sum test was used for inter-group difference analysis of Alpha diversity; LEfSe analysis determined the bacterial groups with significant differences in abundance between different groups from phylum to genus, and species were selected based on spearman correlation for correlation network diagram analysis.